Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
5-fluorouracil (5-FU)
70%
6-thioguanine (6-TG)
27%
Acute Promyelocytic Leukemia Cells
12%
All-trans Retinoic Acid
11%
Angiogenesis
13%
Angiogenic Factors
15%
Antineoplastic
12%
Antitumor Activity
37%
Autophagy Inhibitor
11%
Cell Differentiation
18%
Chromatin
15%
Colon Cancer Cells
19%
Cyclophosphamide
11%
Cytotoxicity
35%
Deoxyribonucleoside Triphosphates
11%
Differentiated Cells
11%
Dimethyl Sulfoxide
25%
Docetaxel
11%
Doxorubicin
12%
Fluorouracil
23%
Granulocyte Colony-stimulating Factor (G-CSF)
18%
Growth Inhibition
11%
HL-60 Cells
56%
HT-29
14%
Human Colon Cancer Cell Line
15%
Human Colon Carcinoma Cells
29%
Human Endothelial Cells
23%
Human Leukemia Cells
20%
Human Promyelocytic Leukemia Cells
11%
Induced Differentiation
27%
Inducer
28%
Interferon-α (IFN-α)
100%
Leukemia Cells
35%
Lung Cancer Cells
11%
Microtubule-targeting Drugs
11%
MYC Expression
11%
Osteosarcoma
17%
Pharmacokinetic Study
17%
Phase I Trial
22%
Platelet-derived Endothelial Cell Growth Factor
19%
Ribonucleotide Reductase
11%
S-phase Kinase-associated Protein 2 (Skp2)
28%
Targeted Inhibition
11%
Taxotere
17%
Thymidine
15%
Thymidine Phosphorylase
65%
Transendothelial Migration
28%
Triphosphate
11%
Tumor
25%
Vascular Endothelial Growth Factor
16%
Pharmacology, Toxicology and Pharmaceutical Science
2-Acetylaminofluorene
11%
Angiogenic Factor
8%
Anthracycline
8%
Anthracycline Antibiotic Agent
8%
Antiangiogenic
13%
Anticarcinogen
16%
Antimetabolite
14%
Antiproliferative Activity
8%
Antitumor Activity
28%
Breast Cancer
17%
Cancer Recurrence
14%
Carcinogenesis
13%
Chemotherapy Regimens
8%
Chloroquine
14%
Clinical Trial
9%
Colon Carcinoma
47%
Colorectal Carcinoma
9%
Cyclophosphamide
11%
Cytotoxic Agent
15%
Cytotoxicity
32%
Deoxyuridine
13%
Dimethyl Sulfoxide
9%
Doxorubicin
18%
Enzymes
15%
Etoposide
11%
Fluoropyrimidine
7%
Fluorouracil
64%
Granulocyte Macrophage Colony Stimulating Factor
7%
Hypoxanthine Phosphoribosyltransferase
8%
Integrin
9%
Interferon
71%
Leukemia
35%
Lung Cancer
11%
Malignant Neoplasm
16%
Marcellomycin
11%
Messenger RNA
7%
Neoplasm
12%
Nitroblue tetrazolium
8%
Paclitaxel
17%
Pharmacokinetics
39%
Phase I Trials
17%
Promyelocytic Leukemia
33%
Purine
7%
Rat
11%
Receptor
8%
Retinoic Acid
14%
Ribonucleotide Reductase
11%
Thymidine Phosphorylase
38%
Tioguanine
22%
Vasculotropin
14%
Biochemistry, Genetics and Molecular Biology
Angiogenesis
8%
Antineoplastic Activity
17%
Autophagy
9%
Cancer Cell
37%
Carcinogenesis
17%
Cell Cycle Checkpoint
8%
Cell Migration
19%
Cell Motility
8%
Cell Proliferation
13%
Chromatin
19%
Colon
35%
Cyclin-Dependent Kinase
7%
Cytotoxicity
24%
Deoxyribonucleoside
11%
Deoxyribose
12%
Dimethyl Sulfoxide
17%
DNA Template
9%
Fluorouracil
24%
Genetics
7%
Granulocyte Macrophage Colony-Stimulating Factor
12%
Integrin
9%
Interferon
25%
Kinase
9%
Knockout Model
7%
Maturation
10%
Messenger RNA
7%
Metabolic Pathway
7%
Mouse Model
17%
N-Acetylmannosamine
7%
Overall Survival
10%
P53
15%
Penetrance
8%
Phosphotransferase
9%
Programmed Cell Death
23%
Proto Oncogene
8%
Rat
8%
Ribonucleotide Reductase
11%
RNA
13%
RNA Sequence
11%
S Phase
16%
Sialic Acid
11%
Thymidine
7%
Thymidine Phosphorylase
16%
Tioguanine
11%
Tumor Suppressor Protein
8%
Ubiquitin Ligase
18%
Ubiquitin-Conjugating Enzyme
11%
Ubiquitination
9%
Vascular Endothelial Growth Factor
8%
Wild Type
12%